RE2 A Detailed Comparison of Dutch and Swedish Drug Reimbursement Decisions- What Evidence is Available, Which Criteria are Used, and is the Decision-Making Process Transparent?

Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.534
https://www.valueinhealthjournal.com/article/S1098-3015(12)02247-4/fulltext
Title : RE2 A Detailed Comparison of Dutch and Swedish Drug Reimbursement Decisions- What Evidence is Available, Which Criteria are Used, and is the Decision-Making Process Transparent?
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02247-4&doi=10.1016/j.jval.2012.08.534
First page : A287
Section Title : Drivers of Reimbursement Technology
Open access? : No
Section Order : 54
Categories :
Tags :
Regions :
ViH Article Tags :